CD40 Ligand Is Required for Protective Cell-Mediated Immunity to Leishmania major
- 1 March 1996
- journal article
- Published by Elsevier BV in Immunity
- Vol. 4 (3), 283-289
- https://doi.org/10.1016/s1074-7613(00)80436-7
Abstract
No abstract availableThis publication has 36 references indexed in Scilit:
- The Regulation of Immunity to Leishmania MajorAnnual Review of Immunology, 1995
- Activated T cells induce interleukin‐12 production by monocytes via CD40‐CD40 ligand interactionEuropean Journal of Immunology, 1995
- Activated T cells enhance nitric oxide production by murine splenic macrophages through gp39 and LFA‐1European Journal of Immunology, 1995
- Structural characteristics of CD40 ligand that determine biological functionSeminars in Immunology, 1994
- Antibody to the ligand of CD40, gp39, blocks the occurrence of the acute and chronic forms of graft-vs-host disease.JCI Insight, 1994
- Mice deficient for the CD40 ligandImmunity, 1994
- CD40 ligand and its role in X-linked hyper-IgM syndromeImmunology Today, 1993
- CD40 ligand is a T cell growth factorEuropean Journal of Immunology, 1993
- Development of T H 1 CD4 + T Cells Through IL-12 Produced by Listeria -Induced MacrophagesScience, 1993
- Molecular and biological characterization of a murine ligand for CD40Nature, 1992